Chapters

Transcript

Video

Pasi Jänne, MD, PhD Discusses Lung Cancer data at AACR24

Dana-Farber's Pasi Jänne, MD, PhD, reports on ctDNA with an EGFR mutation in FLAURA2 trial. The new data shows patients whose blood tested positive before therapy for tumor cell DNA with EGFR mutations stood to gain the most from combination therapy.
 

Published

April 10, 2024

Created by

Dana-Farber

Related Presenters

Pasi A. Jänne, MD, PhD

Pasi A. Jänne, MD, PhD

Medical Oncology

Dr. Jänne received his MD and PhD from the University of Pennsylvania in 1996. He completed postgraduate training in internal medicine at Brigham and Women's Hospital and in medical oncology at DFCI in 2001. He is the director of the Lowe ...

View Full Profile